Localized and systemic scleroderma show different histological responses to methotrexate therapy

Journal of Pathology

Volumn 193, Issue 4, 2001, Pages 511-516

  Seyger, M M B ^a   Van Den Hoogen, F H J ^a   Van Vlijmen Willems, I M J J ^a   Van De Kerkhof, P C M ^a   De Jong, E M G J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Extracellular matrix; Mast cells; Morphoea; Systemic sclerosis; Tenascin

Indexed keywords

METHOTREXATE; PROTEOHEPARAN SULFATE; TENASCIN;

ADULT; ARTICLE; CELL COUNT; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; EPIDERMIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MAST CELL; MORPHEA; PARAMETER; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DEFECT; STAINING; SYSTEMIC SCLEROSIS; TREATMENT OUTCOME;

ADULT; DERMATOLOGIC AGENTS; FEMALE; HEPARIN; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MAST CELLS; METHOTREXATE; MIDDLE AGED; PROTEOGLYCANS; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC; TENASCIN; TREATMENT OUTCOME;

EID: 0035073488     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH779>3.0.CO;2-8     Document Type: Article

References (38)

1. Systemic scleroderma. Clinical and pathophysiologic aspects
2. Localized scleroderma
3. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls
4. Connective tissue alterations in systemic sclerosis
5. Increased expression of tenascin in the dermis in scleroderma
6. Deposition of extracellular matrix along the pathways of migrating fibroblasts
7. Participation of tenascin and transforming growth factor-beta in reciprocal epithelial mesenchymal interactions of MCF7 cells and fibroblasts
8. Immunohistochemical study of basement membrane reconstruction by an epidermis-dermis recombination experiment using cultured chick embryonic skin: Induction of tenascin
9. Tenascin expression during wound healing in human skin
10. Human epidermal keratinocytes are a source of tenascin-C during wound healing
11. Tenascin expression in human dermis is related to epidermal proliferation
12. Tenascin expression in hyperproliferative skin diseases
13. Disaccharide analysis of skin glycosaminoglycan in localized scleroderma
14. Disaccharide analysis of the skin glycosaminoglycans in systemic sclerosis
15. Increased dermal mast cell populations in progressive systemic sclerosis: A link in chronic fibrosis?
16. Increased number of mast cells accompany enhanced collagen synthesis in linear localized scleroderma
17. Comparison of methotrexate with placebo in the treatment of systemic sclerosis: A 24 week randomized double-blind trial, followed by a 24 week observational trial
18. Low dose methotrexate in the treatment of widespread morphea
19. Monoclonal antibodies against the protein core and glycosaminoglycan side chain of glomerular basement membrane heparan sulfate proteoglycan: Characterization and immunohistological application in human tissues
20. A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats
21. Production and characterization of a monoclonal antibody against human glomerular heparan sulfate
22. Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody
23. Nodular scleroderma: Focally increased tenascin expression differing from that in the surrounding scleroderma skin
24. Mast cell changes in a case of rapidly progressive scleroderma - Ultrastructural analysis
25. Mast cells and fibrosis
26. Mast cell numbers in diffuse scleroderma
27. Effects of methotrexate on glycosaminoglycan production by scleroderma fibroblasts in culture
28. The pharmacology and clinical use of methotrexate
29. Methotrexate: Mechanism of action in rheumatoid arthritis
30. Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma
31. Demonstration of interleukin 8 in serum samples of patients with localized scleroderma
32. Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluation in patients with rheumatoid arthritis
33. Increased spontaneous production of IL-8 in peripheral blood monocytes from the psoriatic patient: Relation to focal infection and response to treatments
34. Methotrexate action in rheumatoid arthritis: Stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells
35. IL-4 upregulates tenascin synthesis in scleroderma and healthy skin fibroblasts
36. The effects of cyclosporin A, dexamethasone and other immunomodulatory drugs on induced expression of IL-3, IL-4 and lL-8 mRNA in a human mast cell line
37. Urinary adenosine and aminoimidazolecarboxamide excretion in methotrexate-treated patients with psoriasis